巨头药企纷纷押注细胞治疗,阿斯利康豪掷72亿元收购这家公司

国际金融报
May 23, 2025

2025年,全球各大顶级药企都在不惜重金,全力布局细胞治疗领域。比如,5月20日,阿斯利康(AZ)宣布,斥资72亿元人民币成功完成对比利时生物技术公司EsoBiotec的收购,旨在加速其在细胞治疗领域的布局。早在3月17日,阿斯利康就宣布最高10亿美元的价格收购EsoBiotec,此次收购包括在交易完成时支付4.25亿美元的首付款,以及最高达5.75亿美元的里程碑金额。交易预计将于2025年...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10